Targeting #IRF4 could open a new path for #MultipleMyeloma therapy.
G1126 suppresses myeloma growth, reduces lenalidomide-resistant cells and enhances #chemotherapy response while sparing normal stem cells. @ECNUER
#GenesAndDiseases: doi.org/10.1016/j.ge...